1. Home
  2. BDC vs LEGN Comparison

BDC vs LEGN Comparison

Compare BDC & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Belden Inc

BDC

Belden Inc

HOLD

Current Price

$117.55

Market Cap

5.6B

ML Signal

HOLD

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

HOLD

Current Price

$17.27

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BDC
LEGN
Founded
1902
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6B
5.9B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
BDC
LEGN
Price
$117.55
$17.27
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
13
Target Price
$148.33
$63.08
AVG Volume (30 Days)
305.8K
1.5M
Earning Date
04-30-2026
03-10-2026
Dividend Yield
0.18%
N/A
EPS Growth
23.13
N/A
EPS
5.91
N/A
Revenue
$2,715,194,000.00
N/A
Revenue This Year
$8.91
$46.27
Revenue Next Year
$4.70
$28.77
P/E Ratio
$18.92
N/A
Revenue Growth
10.33
N/A
52 Week Low
$83.18
$16.24
52 Week High
$159.99
$45.30

Technical Indicators

Market Signals
Indicator
BDC
LEGN
Relative Strength Index (RSI) 39.38 38.56
Support Level $113.99 $16.24
Resistance Level $125.01 $20.39
Average True Range (ATR) 4.37 0.80
MACD -1.60 -0.14
Stochastic Oscillator 23.97 5.42

Price Performance

Historical Comparison
BDC
LEGN

About BDC Belden Inc

Belden Inc is a supplier of complete connection solutions. It has two segments, Smart Infrastructure Solutions and Automation Solutions. Smart Infrastructure Solutions provides network infrastructure and broadband solutions, serving markets such as data centers, government, healthcare, and broadband and wireless service providers, with products including copper and fiber cable and connectivity solutions. Automation Solutions provides digitization and automation solutions that enable IT OT convergence and support acquisition, transmission, orchestration, and management, serving markets including Warehousing and Logistics, Energy, Transportation, and Discrete Manufacturing. The company operates in the Americas, EMEA, and APAC, with maximum revenue coming from the Americas.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: